These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 25411045

  • 1. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
    Uchida H, Nagai J, Ueda H.
    Mol Pain; 2014 Nov 19; 10():71. PubMed ID: 25411045
    [Abstract] [Full Text] [Related]

  • 2. An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model.
    Ma L, Nagai J, Chun J, Ueda H.
    Mol Pain; 2013 Jun 17; 9():29. PubMed ID: 23773289
    [Abstract] [Full Text] [Related]

  • 3. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H.
    Mol Pain; 2009 Nov 13; 5():64. PubMed ID: 19912636
    [Abstract] [Full Text] [Related]

  • 4. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H.
    J Pharmacol Exp Ther; 2010 May 13; 333(2):540-6. PubMed ID: 20123931
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
    Inoue M, Ma L, Aoki J, Ueda H.
    J Neurochem; 2008 Dec 13; 107(6):1556-65. PubMed ID: 19014389
    [Abstract] [Full Text] [Related]

  • 6. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.
    Ueda H, Neyama H, Matsushita Y.
    Cells; 2020 Aug 16; 9(8):. PubMed ID: 32824296
    [Abstract] [Full Text] [Related]

  • 7. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
    Murai N, Hiyama H, Kiso T, Sekizawa T, Watabiki T, Oka H, Aoki T.
    Neuropharmacology; 2017 Nov 16; 126():97-107. PubMed ID: 28859883
    [Abstract] [Full Text] [Related]

  • 8. Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice.
    Srikanth M, Chew WS, Hind T, Lim SM, Hay NWJ, Lee JHM, Rivera R, Chun J, Ong WY, Herr DR.
    Eur J Pharmacol; 2018 Dec 15; 841():49-56. PubMed ID: 30321532
    [Abstract] [Full Text] [Related]

  • 9. Blocking the GABA transporter GAT-1 ameliorates spinal GABAergic disinhibition and neuropathic pain induced by paclitaxel.
    Yadav R, Yan X, Maixner DW, Gao M, Weng HR.
    J Neurochem; 2015 Jun 15; 133(6):857-69. PubMed ID: 25827582
    [Abstract] [Full Text] [Related]

  • 10. Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells.
    Fukushima K, Takahashi K, Yamasaki E, Onishi Y, Fukushima N, Honoki K, Tsujiuchi T.
    Exp Cell Res; 2017 Mar 01; 352(1):139-145. PubMed ID: 28189636
    [Abstract] [Full Text] [Related]

  • 11. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ, Liao FF, Dang WH, Ding X, Liu XD, Cai J, Han JS, Wan Y, Xing GG.
    Exp Neurol; 2010 Apr 01; 222(2):256-66. PubMed ID: 20079352
    [Abstract] [Full Text] [Related]

  • 12. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
    Santos-Nogueira E, López-Serrano C, Hernández J, Lago N, Astudillo AM, Balsinde J, Estivill-Torrús G, de Fonseca FR, Chun J, López-Vales R.
    J Neurosci; 2015 Jul 15; 35(28):10224-35. PubMed ID: 26180199
    [Abstract] [Full Text] [Related]

  • 13. Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain.
    Ueda H, Neyama H, Nagai J, Matsushita Y, Tsukahara T, Tsukahara R.
    Pain; 2018 Nov 15; 159(11):2170-2178. PubMed ID: 29939962
    [Abstract] [Full Text] [Related]

  • 14. Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain.
    Ma L, Nagai J, Ueda H.
    J Neurochem; 2010 Nov 15; 115(3):643-53. PubMed ID: 20722972
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.
    Yano R, Ma L, Nagai J, Ueda H.
    Cell Mol Neurobiol; 2013 Nov 15; 33(8):1033-41. PubMed ID: 23949386
    [Abstract] [Full Text] [Related]

  • 16. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
    Inoue M, Ma L, Aoki J, Chun J, Ueda H.
    Mol Pain; 2008 Feb 08; 4():6. PubMed ID: 18261210
    [Abstract] [Full Text] [Related]

  • 17. Bulleyaconitine A depresses neuropathic pain and potentiation at C-fiber synapses in spinal dorsal horn induced by paclitaxel in rats.
    Zhu HQ, Xu J, Shen KF, Pang RP, Wei XH, Liu XG.
    Exp Neurol; 2015 Nov 08; 273():263-72. PubMed ID: 26376216
    [Abstract] [Full Text] [Related]

  • 18. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.
    Nagai J, Uchida H, Matsushita Y, Yano R, Ueda M, Niwa M, Aoki J, Chun J, Ueda H.
    Mol Pain; 2010 Nov 09; 6():78. PubMed ID: 21062487
    [Abstract] [Full Text] [Related]

  • 19. LPA3-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice.
    Wang F, Liu S, Pei J, Cai L, Liu N, Liang T, Dong X, Cong X, Chun J, Chen J, Hu S, Chen X.
    Theranostics; 2020 Nov 09; 10(24):10892-10907. PubMed ID: 33042260
    [Abstract] [Full Text] [Related]

  • 20. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX, Cai J, Li MJ, Chi YN, Liao FF, Liu FY, Wan Y, Han JS, Xing GG.
    Exp Neurol; 2009 Feb 09; 215(2):298-307. PubMed ID: 19046970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.